相似文献
1
Genetic overlap between idiopathic pulmonary fibrosis and COVID-19.
Eur Respir J. 2022 Jul 7;60(1). doi: 10.1183/13993003.03132-2021. Print 2022 Jul.
2
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
EBioMedicine. 2021 Mar;65:103277. doi: 10.1016/j.ebiom.2021.103277. Epub 2021 Mar 10.
3
Idiopathic pulmonary fibrosis: on the move.
Lancet Respir Med. 2014 Jan;2(1):17-9. doi: 10.1016/S2213-2600(13)70240-6. Epub 2013 Dec 23.
4
Cause or consequence in idiopathic pulmonary fibrosis: using genetic data to back the right horse.
Thorax. 2024 Aug 19;79(9):803-804. doi: 10.1136/thorax-2024-222011.
5
Idiopathic pulmonary fibrosis--a sticky business.
N Engl J Med. 2011 Apr 21;364(16):1560-1. doi: 10.1056/NEJMe1014191.
6
Molecular mechanisms in progressive idiopathic pulmonary fibrosis.
Annu Rev Med. 2013;64:265-76. doi: 10.1146/annurev-med-042711-142004. Epub 2012 Sep 27.
7
A haplotype of cyclooxygenase-2 gene is associated with idiopathic pulmonary fibrosis.
Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(2):121-30.
8
Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations.
Am J Respir Crit Care Med. 2021 Mar 15;203(6):775-778. doi: 10.1164/rccm.202008-3211LE.
9
Diaphragmatic Atrophy May Limit Progression of Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2020 May 1;201(9):e72-e73. doi: 10.1164/rccm.201905-0989IM.
10
Will the genes responsible for familial pulmonary fibrosis provide clues to the pathogenesis of IPF?
Am J Respir Crit Care Med. 2010 Dec 1;182(11):1342-3. doi: 10.1164/rccm.201007-1193ED.
引用本文的文献
1
Genome-Wide Association Study of COVID-19 Breakthrough Infections and Genetic Overlap with Other Diseases: A Study of the UK Biobank.
Int J Mol Sci. 2025 Jul 4;26(13):6441. doi: 10.3390/ijms26136441.
2
The respiratory microbiome in patients with post-COVID-19 residual lung abnormalities resembles that of healthy individuals and is distinct from idiopathic pulmonary fibrosis.
ERJ Open Res. 2025 May 27;11(3). doi: 10.1183/23120541.00826-2024. eCollection 2025 May.
3
Polygenic risk of idiopathic pulmonary fibrosis and COVID-19 severity.
ERJ Open Res. 2025 Apr 14;11(2). doi: 10.1183/23120541.00978-2024. eCollection 2025 Mar.
4
Inflammatory and Coagulation Marker Changes in PMX-DHP-Treated COVID-19 Patients.
Cureus. 2025 Feb 10;17(2):e78836. doi: 10.7759/cureus.78836. eCollection 2025 Feb.
5
Update of Aging Hallmarks in Idiopathic Pulmonary Fibrosis.
Cells. 2025 Feb 5;14(3):222. doi: 10.3390/cells14030222.
6
Context-specific eQTLs provide deeper insight into causal genes underlying shared genetic architecture of COVID-19 and idiopathic pulmonary fibrosis.
HGG Adv. 2025 Apr 10;6(2):100410. doi: 10.1016/j.xhgg.2025.100410. Epub 2025 Jan 27.
7
Role of IPF genetic risk loci in post-COVID-19 lung abnormalities: a cohort study.
BMJ Open Respir Res. 2025 Jan 19;12(1):e002725. doi: 10.1136/bmjresp-2024-002725.
8
Serological Biomarkers in Individuals with Interstitial Lung Disease after SARS-CoV-2 Infection and Association with Post-COVID-19 Symptoms.
Pathogens. 2024 Jul 31;13(8):641. doi: 10.3390/pathogens13080641.
9
Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop Report.
Ann Am Thorac Soc. 2024 Sep;21(9):1219-1237. doi: 10.1513/AnnalsATS.202406-651ST.
10
Context-specific eQTLs reveal causal genes underlying shared genetic architecture of critically ill COVID-19 and idiopathic pulmonary fibrosis.
medRxiv. 2024 Jul 14:2024.07.13.24310305. doi: 10.1101/2024.07.13.24310305.
本文引用的文献
1
Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis.
Thorax. 2022 Aug;77(8):829-833. doi: 10.1136/thoraxjnl-2021-218577. Epub 2022 Jun 10.
2
The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.
PLoS Pathog. 2021 Oct 1;17(10):e1009412. doi: 10.1371/journal.ppat.1009412. eCollection 2021 Oct.
3
Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression.
Nat Genet. 2021 Sep;53(9):1300-1310. doi: 10.1038/s41588-021-00913-z. Epub 2021 Sep 2.
4
COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.
Immunol Rev. 2021 Jul;302(1):228-240. doi: 10.1111/imr.12977. Epub 2021 May 24.
5
Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.
Commun Biol. 2021 Mar 23;4(1):392. doi: 10.1038/s42003-021-01910-y.
6
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
EBioMedicine. 2021 Mar;65:103277. doi: 10.1016/j.ebiom.2021.103277. Epub 2021 Mar 10.
7
Genetic mechanisms of critical illness in COVID-19.
Nature. 2021 Mar;591(7848):92-98. doi: 10.1038/s41586-020-03065-y. Epub 2020 Dec 11.
8
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1656-1665. doi: 10.1164/rccm.202007-2794OC.
9
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):303-310. doi: 10.1016/j.dsx.2020.04.004. Epub 2020 Apr 9.
10
DPP9's Enzymatic Activity and Not Its Binding to CARD8 Inhibits Inflammasome Activation.
ACS Chem Biol. 2019 Nov 15;14(11):2424-2429. doi: 10.1021/acschembio.9b00462. Epub 2019 Sep 20.
Zotero 插件